Cargando…

Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase

Heparan Sulfate (HS) is a cell signaling molecule linked to pathological processes ranging from cancer to viral entry, yet fundamental aspects of its biosynthesis remain incompletely understood. Here, the binding preferences of the uronyl 2-O-sulfotransferase (HS2ST) are examined with variably-sulfa...

Descripción completa

Detalles Bibliográficos
Autores principales: Thieker, David F., Xu, Yongmei, Chapla, Digantkumar, Nora, Chelsea, Qiu, Hong, Felix, Thomas, Wang, Lianchun, Moremen, Kelley W., Liu, Jian, Esko, Jeffrey D., Woods, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081452/
https://www.ncbi.nlm.nih.gov/pubmed/30087361
http://dx.doi.org/10.1038/s41598-018-29602-4
_version_ 1783345652857569280
author Thieker, David F.
Xu, Yongmei
Chapla, Digantkumar
Nora, Chelsea
Qiu, Hong
Felix, Thomas
Wang, Lianchun
Moremen, Kelley W.
Liu, Jian
Esko, Jeffrey D.
Woods, Robert J.
author_facet Thieker, David F.
Xu, Yongmei
Chapla, Digantkumar
Nora, Chelsea
Qiu, Hong
Felix, Thomas
Wang, Lianchun
Moremen, Kelley W.
Liu, Jian
Esko, Jeffrey D.
Woods, Robert J.
author_sort Thieker, David F.
collection PubMed
description Heparan Sulfate (HS) is a cell signaling molecule linked to pathological processes ranging from cancer to viral entry, yet fundamental aspects of its biosynthesis remain incompletely understood. Here, the binding preferences of the uronyl 2-O-sulfotransferase (HS2ST) are examined with variably-sulfated hexasaccharides. Surprisingly, heavily sulfated oligosaccharides formed by later-acting sulfotransferases bind more tightly to HS2ST than those corresponding to its natural substrate or product. Inhibition assays also indicate that the IC(50) values correlate simply with degree of oligosaccharide sulfation. Structural analysis predicts a mode of inhibition in which 6-O-sulfate groups located on glucosamine residues present in highly-sulfated oligosaccharides occupy the canonical binding site of the nucleotide cofactor. The unexpected finding that oligosaccharides associated with later stages in HS biosynthesis inhibit HS2ST indicates that the enzyme must be separated temporally and/or spatially from downstream products during biosynthesis in vivo, and highlights a challenge for the enzymatic synthesis of lengthy HS chains in vitro.
format Online
Article
Text
id pubmed-6081452
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60814522018-08-10 Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase Thieker, David F. Xu, Yongmei Chapla, Digantkumar Nora, Chelsea Qiu, Hong Felix, Thomas Wang, Lianchun Moremen, Kelley W. Liu, Jian Esko, Jeffrey D. Woods, Robert J. Sci Rep Article Heparan Sulfate (HS) is a cell signaling molecule linked to pathological processes ranging from cancer to viral entry, yet fundamental aspects of its biosynthesis remain incompletely understood. Here, the binding preferences of the uronyl 2-O-sulfotransferase (HS2ST) are examined with variably-sulfated hexasaccharides. Surprisingly, heavily sulfated oligosaccharides formed by later-acting sulfotransferases bind more tightly to HS2ST than those corresponding to its natural substrate or product. Inhibition assays also indicate that the IC(50) values correlate simply with degree of oligosaccharide sulfation. Structural analysis predicts a mode of inhibition in which 6-O-sulfate groups located on glucosamine residues present in highly-sulfated oligosaccharides occupy the canonical binding site of the nucleotide cofactor. The unexpected finding that oligosaccharides associated with later stages in HS biosynthesis inhibit HS2ST indicates that the enzyme must be separated temporally and/or spatially from downstream products during biosynthesis in vivo, and highlights a challenge for the enzymatic synthesis of lengthy HS chains in vitro. Nature Publishing Group UK 2018-08-07 /pmc/articles/PMC6081452/ /pubmed/30087361 http://dx.doi.org/10.1038/s41598-018-29602-4 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Thieker, David F.
Xu, Yongmei
Chapla, Digantkumar
Nora, Chelsea
Qiu, Hong
Felix, Thomas
Wang, Lianchun
Moremen, Kelley W.
Liu, Jian
Esko, Jeffrey D.
Woods, Robert J.
Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase
title Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase
title_full Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase
title_fullStr Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase
title_full_unstemmed Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase
title_short Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase
title_sort downstream products are potent inhibitors of the heparan sulfate 2-o-sulfotransferase
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081452/
https://www.ncbi.nlm.nih.gov/pubmed/30087361
http://dx.doi.org/10.1038/s41598-018-29602-4
work_keys_str_mv AT thiekerdavidf downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase
AT xuyongmei downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase
AT chapladigantkumar downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase
AT norachelsea downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase
AT qiuhong downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase
AT felixthomas downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase
AT wanglianchun downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase
AT moremenkelleyw downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase
AT liujian downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase
AT eskojeffreyd downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase
AT woodsrobertj downstreamproductsarepotentinhibitorsoftheheparansulfate2osulfotransferase